Literature DB >> 10630644

Growth factor signaling pathways in vascular development.

M D Tallquist1, P Soriano, R A Klinghoffer.   

Abstract

Recent research on the formation and maintenance of the vasculature in the embryo and in the adult has provided a greater understanding of the cellular signals involved in these processes. With this understanding comes the potential means of controlling vascularization in pathological situations such as tumorigenesis and wounding. For the purpose of this review, we will discuss the key receptor tyrosine kinases involved in vascular function and the molecules which relay signals downstream of receptor activation. The receptor tyrosine kinases discussed include the vascular endothelial cell growth factor receptors, Eph receptors, Tie1, and Tie2, all of which are expressed on vascular endothelial cells. We also discuss the roles of the platelet derived growth factor receptors which are expressed on vascular smooth muscle cells. While all of these receptor tyrosine kinases activate many similar effector molecules, some of the signals initiated appear to be distinct. This may explain, at least in part, how different receptor tyrosine kinases expressed in overlapping patterns on the developing vasculature, direct unique biological functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630644     DOI: 10.1038/sj.onc.1203216

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Notch signaling during vascular development.

Authors:  T Gridley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors.

Authors:  Wiem Lassoued; Danielle Murphy; Jeff Tsai; Ridha Oueslati; Gavin Thurston; William M F Lee
Journal:  Cancer Biol Ther       Date:  2010-12-15       Impact factor: 4.742

3.  The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.

Authors:  Nathalie Kertesz; Valery Krasnoperov; Ramachandra Reddy; Lucy Leshanski; S Ram Kumar; Sergey Zozulya; Parkash S Gill
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

4.  Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis.

Authors:  Takashi Kojima; Jin-Hong Chang; Dimitri T Azar
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

5.  CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.

Authors:  S V Bhagwat; J Lahdenranta; R Giordano; W Arap; R Pasqualini; L H Shapiro
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

Review 6.  Cardiac outflow tract anomalies.

Authors:  Zachary Neeb; Jacquelyn D Lajiness; Esther Bolanis; Simon J Conway
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013-02-19       Impact factor: 5.814

Review 7.  Genes that regulate metastasis and angiogenesis.

Authors:  C P Webb; G F Vande Woude
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

8.  STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.

Authors:  Xing-Hua Liao; Nan Wang; Dong-Wei Zhao; De-Liang Zheng; Li Zheng; Wen-Jing Xing; Wen-Jian Ma; Le-Yuan Bao; Jian Dong; Tong-Cun Zhang
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

9.  Activated STAT3 is a mediator and biomarker of VEGF endothelial activation.

Authors:  Shao-Hua Chen; Danielle A Murphy; Wiem Lassoued; Gavin Thurston; Michael D Feldman; William M F Lee
Journal:  Cancer Biol Ther       Date:  2008-12-11       Impact factor: 4.742

10.  Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.

Authors:  Tatsuya Onguchi; Kyu Yeon Han; Jin-Hong Chang; Dimitri T Azar
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.